ARIMIDEX is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Anastrozole.
| Product ID | 0310-0201_a11a1b6f-a483-457d-92c2-6140f6b2d83e |
| NDC | 0310-0201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ARIMIDEX |
| Generic Name | Anastrozole |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1996-01-16 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA / DRUG FOR FURTHER PROCESSING |
| Application Number | NDA020541 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | ANASTROZOLE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020541 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-09-05 |
| Marketing End Date | 2013-10-31 |
| Marketing Category | NDA |
| Application Number | NDA020541 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-01-16 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA |
| Application Number | NDA020541 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-09-15 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA |
| Application Number | NDA020541 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2008-06-02 |
| Marketing End Date | 2012-07-30 |
| Ingredient | Strength |
|---|---|
| ANASTROZOLE | 1 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-0201 | ARIMIDEX | Anastrozole |
| 62559-670 | ARIMIDEX | ARIMIDEX |
| 0093-7536 | Anastrozole | Anastrozole |
| 0904-6195 | Anastrozole | Anastrozole |
| 16571-421 | Anastrozole | Anastrozole |
| 16729-035 | Anastrozole | Anastrozole |
| 21695-990 | Anastrozole | Anastrozole |
| 42254-161 | Anastrozole | Anastrozole |
| 42291-085 | Anastrozole | Anastrozole |
| 43063-383 | ANASTROZOLE | ANASTROZOLE |
| 45865-909 | Anastrozole | Anastrozole |
| 50090-2005 | Anastrozole | Anastrozole |
| 50090-2453 | Anastrozole | Anastrozole |
| 50090-5002 | ANASTROZOLE | ANASTROZOLE |
| 50090-5812 | Anastrozole | Anastrozole |
| 50268-075 | ANASTROZOLE | ANASTROZOLE |
| 51655-638 | Anastrozole | Anastrozole |
| 51991-620 | ANASTROZOLE | ANASTROZOLE |
| 59651-236 | Anastrozole | Anastrozole |
| 60429-286 | Anastrozole | Anastrozole |
| 60505-2985 | Anastrozole | Anastrozole |
| 60687-112 | Anastrozole | Anastrozole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ARIMIDEX 78731027 3726705 Dead/Cancelled |
AstraZeneca UK Limited 2005-10-11 |
![]() ARIMIDEX 77455690 3611359 Dead/Cancelled |
AstraZeneca UK Limited 2008-04-23 |
![]() ARIMIDEX 73794256 1753552 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1989-04-19 |